Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model? - Wikidata - wikimedia - TriplyDB

Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?

Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?

http://www.wikidata.org/entity/Q37205008

about

Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint Quantitative assessment of acute kidney injury by noninvasive arterial spin labeling perfusion MRI: a pilot study.Monitoring the vascular response and resistance to sunitinib in renal cell carcinoma in vivo with susceptibility contrast MRI.Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression.The role of angiopoietins as potential therapeutic targets in renal cell carcinoma.Targeted therapies in renal cell cancer: recent developments in imaging Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling.Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer.High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma.Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma MRI phenotype in renal cancer: is it clinically relevant?Hepatic arterial spin labelling MRI: an initial evaluation in mice.Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings.Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments.Volumetric Arterial Spin-labeled Perfusion Imaging of the Kidneys with a Three-dimensional Fast Spin Echo Acquisition Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma.Early detection of antiangiogenic treatment responses in a mouse xenograft tumor model using quantitative perfusion MRI.Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTOR.Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: new strategies for overcoming resistance to VEGFR and mTORC1 inhibitors.Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging.Value of intravoxel incoherent motion in assessment of pathological grade of clear cell renal cell carcinoma.Optimization of arterial spin labeling MRI for quantitative tumor perfusion in a mouse xenograft model.The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma.Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma Rapid development of hypertension by sorafenib: toxicity or target?Perfusion of surgical cavity wall enhancement in early post-treatment MR imaging may stratify the time-to-progression in glioblastoma.Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma.Quantitative Methods in Abdominal MRI: Perfusion Imaging.Perfusion imaging of brain gliomas using arterial spin labeling: correlation with histopathological vascular density in MRI-guided biopsies.Quantification of renal perfusion: comparison of arterial spin labeling and dynamic contrast-enhanced MRI.[Functional magnetic resonance imaging of the kidneys].Combination therapy of radiofrequency ablation and bevacizumab monitored with power Doppler ultrasound in a murine model of hepatocellular carcinoma

P2860

Q28816970-B6B5CF8F-B2EB-4ED0-BA01-9BEE2C999FF9 Q30641728-66203B02-C09C-4230-B156-23736976D49F Q32176092-3CA8AB40-1E43-4075-960E-883CC08F3730 Q33760578-93D78D14-6D28-4FE4-B3FB-FB823079EC22 Q33895119-067BF9CA-57CC-4E22-B5D5-20525AD317FB Q33912405-0D0959EF-71B6-4C3C-BADB-671B96B62012 Q34088696-629F7473-9CC9-4CAB-86E2-F60AE0F63AE5 Q34205907-22483302-656B-4B30-BDE6-0CC89DE22996 Q35290386-F69D736A-4266-4C9F-9C3E-B76BEF1333EA Q35568516-5287072C-9B5C-4390-A0D8-0A57AC5EE646 Q35672426-D205738A-C135-4127-AD60-745DE554EE5C Q35675548-06A37C6C-B389-468A-98C1-68DBC4B151B5 Q35793032-5ECD8BAF-F137-4FCE-8A8C-EC854B6291D6 Q36348521-9647002C-5082-49CF-8EB0-639CE80B0574 Q36417718-2001650B-9ACD-4E0C-A83D-302003EC98DE Q36421776-49D4B426-EB7A-4519-A859-0A8A428103B7 Q36471277-57C03766-157A-4580-992E-9BE101BA65CF Q36594073-F7EAC1E9-105C-4BC5-8E6F-740814C1503A Q36798652-969AB42B-2CA6-4F5B-9209-45CF41DD29EF Q36932216-8FEAAC3A-AA01-4811-B510-3494B687FE70 Q37520379-55BDADA4-286B-4041-A93E-DAD7CE56C6DA Q37595237-B167B0B9-F113-40EF-8351-24C23B9C309B Q37965053-49902017-856E-4932-87E0-B1295AFDCB2F Q38068584-A6047A34-D848-4B52-8444-E360D5E6D373 Q38074121-5A34CC9F-1F02-40FB-8556-F84E041C41B8 Q38269850-8E99B054-2492-4275-ADC0-1D2968E89013 Q38710174-4A5F48B7-7981-4EAB-AD4E-3EAF3A8A6D58 Q38860709-0004208A-0E86-4D9C-9658-17A547696FBA Q38950573-2975306C-2C96-467C-B0C2-74B9EA3A4D26 Q39281721-C6FC0E55-37E5-4316-AE7C-F3028B367A10 Q39943166-C8091D50-A468-4FBF-AB08-F76D44814710 Q41090550-F609C630-26FE-4BB1-8948-300537BBB5F2 Q41549055-D28D3B88-C28F-4908-90EF-B3B05D823674 Q47109500-E4968BFD-A0C2-4A16-9559-60F0963A7196 Q47412444-E47FAA84-7FB3-46AB-9B24-DEC221967240 Q48403872-C083D929-64A7-47A1-827B-EC5802771223 Q51548240-04A18BEB-9F35-4EB6-A261-C0441784800F Q52987409-F106445C-0488-47B4-A3D8-F73E25141562 Q57317511-96991FC6-C21D-4DD7-A040-C49B337FFB20

P2860

Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?

http://www.wikidata.org/entity/Q37205008

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Does arterial spin-labeling MR ...... enic therapy in a mouse model?

@en

Does arterial spin-labeling MR ...... enic therapy in a mouse model?

@nl

type

label

Does arterial spin-labeling MR ...... enic therapy in a mouse model?

@en

Does arterial spin-labeling MR ...... enic therapy in a mouse model?

@nl

prefLabel

Does arterial spin-labeling MR ...... enic therapy in a mouse model?

@en

Does arterial spin-labeling MR ...... enic therapy in a mouse model?

@nl

P1433

Q37205008-8B621418-9871-428A-999A-D5C66731B187

P1476

Q37205008-EF087C55-C484-4F35-8A43-CFA3D8F052E7

P2093

Q37205008-0C165983-5F1F-48F6-9643-B3D84E0D6347

Q37205008-4B1BC7A6-5801-444B-82A6-DAA1E407DC25

Q37205008-530DC957-6D9B-46B7-9848-5540CC75167E

Q37205008-7249D45B-BD81-417D-B648-F39E7A097596

Q37205008-7744E29D-6D8B-4F22-939E-5E7083F0D52D

Q37205008-7B46399F-E6EE-4B17-AACC-26A9A88E692C

Q37205008-84058983-D7B6-4A3E-B362-61E8A381CF49

Q37205008-8B5CC8A2-77B8-4E67-9CA7-29E191681E08

Q37205008-A6BE07C6-D476-455B-8F81-21319E2891EA

P2860

Q37205008-01657A81-9570-4924-8EB2-B8DB1A61D6D9

Q37205008-06244810-B5C1-44B8-AFC8-7E45528BE1CB

Q37205008-0AE8D986-07D3-4D9C-AD68-A21029B67FDD

Q37205008-0C15B2D6-2205-4A42-B87D-D440BEE08FCD

Q37205008-0C93C759-9F9E-488F-9EEC-0BE27F823989

Q37205008-14D0192A-1A91-4623-AF38-5E09CB003128

Q37205008-161A4716-7950-41A7-98F0-766E9CB1444F

Q37205008-18DAE003-0479-4303-9F96-B4EF59FD2FBC

Q37205008-1FC33481-B9E4-4F84-BBEF-4027E38C6AF6

Q37205008-2C3CFF5B-482E-439F-B87A-9DBEB69AF27C

P304

Q37205008-204E2117-96B7-4257-B6A9-9B352C0AD29C

P31

Q37205008-63B017A5-6790-4268-AB19-B55B54B55CA1

P356

Q37205008-A52459CF-E27F-4C9C-ACD6-CAEAFD4B2F92

P407

Q37205008-3EDF3C0F-AED6-4A64-B58D-5BF965D6B06E

P433

Q37205008-3F9156FE-642B-4305-A22C-E22C1F5E0310

P478

Q37205008-F4DE6879-DF65-495B-A86A-F300135B08AE

P50

Q37205008-5E26FEFA-BD22-4FF6-AA04-03B7753BB4A8

Q37205008-8866954E-7C45-42D3-A78E-39BC777B2591

P577

Q37205008-5ECE09C4-A8B0-41CD-ABC0-C0E8C5C0091C

P5875

Q37205008-474D7F3E-8DF2-407B-A8F1-3EEF14A057C1

P698

Q37205008-F9C835E3-3EAF-4341-821F-9560C2C547CB

P932

Q37205008-F38BC689-8809-4A59-8D3B-D94AFADBFF3F

P356

RADIOL.2521081059

P1433

P1476

Does arterial spin-labeling MR ...... enic therapy in a mouse model?

@en

P2093

Ivan Pedrosa

http://www.w3.org/2001/XMLSchema#string

Meredith Regan

http://www.w3.org/2001/XMLSchema#string

Michael B Atkins

http://www.w3.org/2001/XMLSchema#string

Rachel Schor-Bardach

http://www.w3.org/2001/XMLSchema#string

Robert P Marquis

http://www.w3.org/2001/XMLSchema#string

S Nahum Goldberg

http://www.w3.org/2001/XMLSchema#string

Sabina Signoretti

http://www.w3.org/2001/XMLSchema#string

Stephanie A Solazzo

http://www.w3.org/2001/XMLSchema#string

Xiaoen Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib in advanced clear-cell renal-cell carcinoma

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system.

Efficiency of inversion pulses for background suppressed arterial spin labeling.

Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques.

A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas.

Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling.

Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease.

Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.

MRI of tumor angiogenesis.

P304

731-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.2521081059

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

251

http://www.w3.org/2001/XMLSchema#string

P50

Robert E. Lenkinski

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26245730

http://www.w3.org/2001/XMLSchema#string

P698

19474376

http://www.w3.org/2001/XMLSchema#string

P932

2687534

http://www.w3.org/2001/XMLSchema#string